Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach

Anirban Goutam Mukherjee; Uddesh Ramesh Wanjari; Arunraj Namachivayam; Reshma Murali; D. S. Prabakaran; Raja Ganesan; Kaviyarasi Renu; Abhijit Dey; Balachandar Vellingiri; Gnanasambandan Ramanathan; George Priya Doss C.; Abilash Valsala Gopalakrishnan

doi:10.3390/vaccines10091493

Vaccines (Sep 2022)

Role of Immune Cells and Receptors in Cancer Treatment: An Immunotherapeutic Approach

Anirban Goutam Mukherjee,
Uddesh Ramesh Wanjari,
Arunraj Namachivayam,
Reshma Murali,
D. S. Prabakaran,
Raja Ganesan,
Kaviyarasi Renu,
Abhijit Dey,
Balachandar Vellingiri,
Gnanasambandan Ramanathan,
George Priya Doss C.,
Abilash Valsala Gopalakrishnan

Affiliations

Anirban Goutam Mukherjee: Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, India
Uddesh Ramesh Wanjari: Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, India
Arunraj Namachivayam: Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, India
Reshma Murali: Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, India
D. S. Prabakaran: Department of Radiation Oncology, College of Medicine, Chungbuk National University, Chungdae-ro 1, Seowon-gu, Cheongju 28644, Korea
Raja Ganesan: Institute for Liver and Digestive Diseases, Hallym University, Chuncheon 24252, Korea
Kaviyarasi Renu: Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College & Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai 600077, Tamil Nadu, India
Abhijit Dey: Department of Life Sciences, Presidency University, Kolkata 700073, West Bengal, India
Balachandar Vellingiri: Human Molecular Cytogenetics and Stem Cell Laboratory, Department of Human Genetics and Molecular Biology, Bharathiar University, Coimbatore 641046, Tamil Nadu, India
Gnanasambandan Ramanathan: Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, India
George Priya Doss C.: Department of Integrative Biology, School of Bio Sciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, India
Abilash Valsala Gopalakrishnan: Department of Biomedical Sciences, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore 632014, Tamil Nadu, India

DOI: https://doi.org/10.3390/vaccines10091493
Journal volume & issue: Vol. 10, no. 9
p. 1493

Abstract

Read online

Cancer immunotherapy moderates the immune system’s ability to fight cancer. Due to its extreme complexity, scientists are working to put together all the puzzle pieces to get a clearer picture of the immune system. Shreds of available evidence show the connection between cancer and the immune system. Immune responses to tumors and lymphoid malignancies are influenced by B cells, γδT cells, NK cells, and dendritic cells (DCs). Cancer immunotherapy, which encompasses adoptive cancer therapy, monoclonal antibodies (mAbs), immune checkpoint therapy, and CART cells, has revolutionized contemporary cancer treatment. This article reviews recent developments in immune cell regulation and cancer immunotherapy. Various options are available to treat many diseases, particularly cancer, due to the progress in various immunotherapies, such as monoclonal antibodies, recombinant proteins, vaccinations (both preventative and curative), cellular immunotherapies, and cytokines.

Published in Vaccines

ISSN: 2076-393X (Online)
Publisher: MDPI AG
Country of publisher: Switzerland
LCC subjects: Medicine
Website: http://www.mdpi.com/journal/vaccines

About the journal

Abstract

Keywords